Aneurysmal Subarachnoid Hemorrhage Risk Assessment Model Identifies Patients for Safe Early Discharge at Day 15-The SAFE-SaH Score.

IF 3.1 3区 医学 Q2 CLINICAL NEUROLOGY
Eric E Kennison, Nick M Murray, Dave S Collingridge, Daniel Knox, Gabriel V Fontaine
{"title":"Aneurysmal Subarachnoid Hemorrhage Risk Assessment Model Identifies Patients for Safe Early Discharge at Day 15-The SAFE-SaH Score.","authors":"Eric E Kennison, Nick M Murray, Dave S Collingridge, Daniel Knox, Gabriel V Fontaine","doi":"10.1007/s12028-025-02236-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with aneurysmal subarachnoid hemorrhage (aSAH) are often hospitalized for 21 days after aneurysm rupture due to the risk of complications. However, some never experience complications and are unlikely to benefit from a prolonged hospitalization. The aim of this study is to derive a risk assessment model (RAM) using data from the first 14 days of hospitalization to identify low-risk patients for early discharge, at day 15 or after.</p><p><strong>Methods: </strong>Patients ≥ 18 years old with an acute aSAH at a Comprehensive Stroke Center from 2017 to 2024 were included. Baseline demographics, aSAH grading scales, and in-hospital complications requiring intervention were characterized. Complications included: vasospasm, delayed cerebral ischemia (DCI), cerebral salt wasting (CSW), cerebral edema, seizures, arrhythmias, respiratory failure, and hydrocephalus. Binary logistic regression with leave-one-out cross validation (LOOCV) was used to identify an optimal RAM.</p><p><strong>Results: </strong>Of 165 patients, the mean Hunt Hess Score (HHS) was 2.5 (standard deviation, SD 1.2), modified Fisher Score (mFS) was 3.1 (SD 1), endovascular therapy was used for aneurysm securement in 73% of patients, and 54.5% of patients experienced complications during days 15-21. In bivariate analyses, days 0-14 variables associated with days 15 + complications were the following: HHS, mFS, middle cerebral artery (MCA) aneurysm, clinical or radiologic vasospasm, endovascular therapies, intraventricular hemorrhage, hydrocephalus, presence of external ventricular drain (EVD), mechanical ventilation, vasopressors, hypertonic solutions, antiseizure medications, milrinone, and fludrocortisone (all p < 0.05). LOOCV regression for a best fit RAM included six variables: Sum of Vasopressors, Artery (MCA aneurysm), Fludrocortisone, EVD, Scale (mFS and HHS), \"SAFE-SaH\" and had an area under the receiver operator characteristics curve of 0.90 (95% confidence interval 0.85-0.95), sensitivity of 0.94, specificity of 0.69, positive predictive value of 79%, and negative predictive value of 91% for predicting complications on day 15 + .</p><p><strong>Conclusions: </strong>This is the first ever RAM to incorporate clinical data from the first 14 days of hospitalization to identify patients with an aSAH at low risk for complications after day 14. With 94% sensitivity, the RAM classifies patients who will not have complications and may assist in earlier disposition on day 15 or after.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurocritical Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12028-025-02236-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patients with aneurysmal subarachnoid hemorrhage (aSAH) are often hospitalized for 21 days after aneurysm rupture due to the risk of complications. However, some never experience complications and are unlikely to benefit from a prolonged hospitalization. The aim of this study is to derive a risk assessment model (RAM) using data from the first 14 days of hospitalization to identify low-risk patients for early discharge, at day 15 or after.

Methods: Patients ≥ 18 years old with an acute aSAH at a Comprehensive Stroke Center from 2017 to 2024 were included. Baseline demographics, aSAH grading scales, and in-hospital complications requiring intervention were characterized. Complications included: vasospasm, delayed cerebral ischemia (DCI), cerebral salt wasting (CSW), cerebral edema, seizures, arrhythmias, respiratory failure, and hydrocephalus. Binary logistic regression with leave-one-out cross validation (LOOCV) was used to identify an optimal RAM.

Results: Of 165 patients, the mean Hunt Hess Score (HHS) was 2.5 (standard deviation, SD 1.2), modified Fisher Score (mFS) was 3.1 (SD 1), endovascular therapy was used for aneurysm securement in 73% of patients, and 54.5% of patients experienced complications during days 15-21. In bivariate analyses, days 0-14 variables associated with days 15 + complications were the following: HHS, mFS, middle cerebral artery (MCA) aneurysm, clinical or radiologic vasospasm, endovascular therapies, intraventricular hemorrhage, hydrocephalus, presence of external ventricular drain (EVD), mechanical ventilation, vasopressors, hypertonic solutions, antiseizure medications, milrinone, and fludrocortisone (all p < 0.05). LOOCV regression for a best fit RAM included six variables: Sum of Vasopressors, Artery (MCA aneurysm), Fludrocortisone, EVD, Scale (mFS and HHS), "SAFE-SaH" and had an area under the receiver operator characteristics curve of 0.90 (95% confidence interval 0.85-0.95), sensitivity of 0.94, specificity of 0.69, positive predictive value of 79%, and negative predictive value of 91% for predicting complications on day 15 + .

Conclusions: This is the first ever RAM to incorporate clinical data from the first 14 days of hospitalization to identify patients with an aSAH at low risk for complications after day 14. With 94% sensitivity, the RAM classifies patients who will not have complications and may assist in earlier disposition on day 15 or after.

动脉瘤性蛛网膜下腔出血风险评估模型确定患者在第15天安全出院- sah评分。
背景:动脉瘤性蛛网膜下腔出血(aSAH)患者在动脉瘤破裂后往往住院21天,因为存在并发症的风险。然而,有些人从未经历过并发症,也不太可能从长期住院治疗中获益。本研究的目的是利用住院前14天的数据得出风险评估模型(RAM),以确定低风险患者在第15天或之后提前出院。方法:纳入2017年至2024年在综合卒中中心就诊的≥18岁急性aSAH患者。基线人口统计学、aSAH分级量表和需要干预的院内并发症的特征。并发症包括:血管痉挛、迟发性脑缺血(DCI)、脑盐消耗(CSW)、脑水肿、癫痫发作、心律失常、呼吸衰竭和脑积水。采用二元逻辑回归与留一交叉验证(LOOCV)来确定最佳RAM。结果:165例患者中,平均Hunt Hess评分(HHS)为2.5(标准差,SD 1.2),改良Fisher评分(mFS)为3.1 (SD 1), 73%的患者采用血管内治疗进行动脉瘤固定,54.5%的患者在15-21天出现并发症。在双变量分析中,与15天以上并发症相关的第0-14天变量为:HHS、mFS、大脑中动脉(MCA)动脉瘤、临床或放射学血管痉挛、血管内治疗、脑室内出血、脑积水、室外引流(EVD)的存在、机械通气、血管加压剂、高渗溶液、抗癫痫药物、米力酮和氟化可的松(均为p)。这是有史以来第一个纳入住院前14天临床数据的RAM,以确定14天后并发症风险低的aSAH患者。RAM具有94%的敏感性,可对无并发症的患者进行分类,并可在第15天或之后协助早期处理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurocritical Care
Neurocritical Care 医学-临床神经学
CiteScore
7.40
自引率
8.60%
发文量
221
审稿时长
4-8 weeks
期刊介绍: Neurocritical Care is a peer reviewed scientific publication whose major goal is to disseminate new knowledge on all aspects of acute neurological care. It is directed towards neurosurgeons, neuro-intensivists, neurologists, anesthesiologists, emergency physicians, and critical care nurses treating patients with urgent neurologic disorders. These are conditions that may potentially evolve rapidly and could need immediate medical or surgical intervention. Neurocritical Care provides a comprehensive overview of current developments in intensive care neurology, neurosurgery and neuroanesthesia and includes information about new therapeutic avenues and technological innovations. Neurocritical Care is the official journal of the Neurocritical Care Society.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信